Academic Journal
Q1European Journal of Haematology
About European Journal of Haematology
European Journal of Haematology is a scholarly journal published by John Wiley and Sons Inc. SCImago 2025 lists it in Q1, with an SJR of 0.977 and H-index of 102.
Coverage: 1986-2026. Research categories: Medicine (miscellaneous) (Q1); Hematology (Q2).
Verified field sources
- Editor(s): Karl-Anton Kreuzer (Editor) — Official source; checked 2026-10-03. Editorial leadership listed under Edited By on the Wiley journal homepage; publisher role retained without assuming Editor-in-Chief.
- Journal Impact Factor: 2.6 — Official source; checked 2026-10-03. Journal Impact Factor and reporting year from Wiley Journal Metrics, distinct from CiteScore and Journal Citation Indicator.
- Impact Factor year: 2025 — Official source; checked 2026-10-03. Journal Impact Factor and reporting year from Wiley Journal Metrics, distinct from CiteScore and Journal Citation Indicator.
Source-backed journal facts
Topics in published research
Acute Myeloid Leukemia Research; Lymphoma Diagnosis and Treatment; Chronic Lymphocytic Leukemia Research; Multiple Myeloma Research and Treatments; Hemoglobinopathies and Related Disorders; Hematopoietic Stem Cell Transplantation.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Reported open-access list prices
4,650.00 USD; 3,920.00 EUR; 3,070.00 GBP
APC list prices reported by OpenAlex, which obtains this information from DOAJ. Confirm current charges, taxes, waivers and eligibility with the publisher; this is not a fee quotation.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
Composite Complication Endpoints May Obscure Bleeding Risk in Pediatric Central Venous Catheterization
Ramazan Ozdemir, Ercan Yılmaz
2026-10-04 · DOI: 10.1111/ejh.70329HMOX1 ‐Associated Neutrophil Engraftment in Pediatric HSCT Requires Evidence Beyond an Early Time Window
Ercan Yılmaz, Nezihe Koker Özer, Erdem Topal
2026-10-02 · DOI: 10.1111/ejh.70324Beyond Extranodal Site Count: Clinical and Anatomical Characterization of Primary Multifocal Extranodal Diffuse Large B‐Cell Lymphoma
Thomas P. Thomopoulos, Christina Apostolopoulou, Pinelopi Vryttia, Anthi Bouchla et al.
2026-10-01 · DOI: 10.1111/ejh.70335Patient and Healthcare Provider Satisfaction With Subcutaneous Versus Intravenous Administration of Daratumumab in Combination With Lenalidomide and Dexamethasone as First‐Line Treatment in Patients With Newly Diagnosed Non‐Transplant Eligible Multiple Myeloma: Final Results of the MYLENE Study
Eyck von der Heyde, Marcel Reiser, Vanessa Baumgartner, Christian Englisch et al.
2026-10-01 · DOI: 10.1111/ejh.70333Steroid Response Prediction in Children With Diamond–Blackfan Anemia Requires Age at Treatment, Not Diagnosis
Ercan Yılmaz, Nezihe Koker Özer, Erdem Topal
2026-09-30 · DOI: 10.1111/ejh.70326BCMA Targeted Therapies and Their Impact on Outcomes in Relapsed or Refractory Multiple Myeloma: Results From the French EMMY Cohort
Titouan Cazaubiel, Olivier Decaux, Aurore Perrot, Bruno Royer et al.
2026-09-29 · DOI: 10.1111/ejh.70334Comment on Sakthivel Et al., “Central Venous Access Device Complications in Children With Leukemia: A Systematic Review and Meta‐Analysis”
Didem Tatar, Ercan Yılmaz, Nezihe Köker Özer
2026-09-25 · DOI: 10.1111/ejh.70325Castleman Disease: Unraveling Diagnostic Challenges Through Clinical and Pathologic Perspectives
Aditi Saha, Lubomir Sokol, Ling Zhang
2026-09-23 · DOI: 10.1111/ejh.70298Posaconazole Prophylaxis for the Prevention of Invasive Fungal Infections in Patients With Hematologic Malignancies: A Systematic Review and Meta‐Analysis
Kasidis Phongkhun, May Soe Thu, Nattiya Hirankarn, Arsa Thammahong et al.
2026-09-21 · DOI: 10.1111/ejh.70332Ferritin Normalization Is Not Disease Control in HFE ‐Related Hemochromatosis: Residual Risk, Transferrin Saturation, and the Hepcidin–Ferroportin Axis
Naga Praneeth Raja
2026-09-20 · DOI: 10.1111/ejh.70327From Association to Prevention: Validating SGLT2 Inhibition Across the MGUS ‐Myeloma Continuum
Pooja Rani, Rajesh Prasad Jayaswal
2026-09-20 · DOI: 10.1111/ejh.70331TP53 ‐Altered Aggressive Large B‐Cell Lymphoma ( LBCL ) Outcomes by Treatment Modality: A Multicenter Cohort From 14 US Centers
Cassandra Duarte, Grace N. Bosma, Diana Abbott, Gaston Jean‐Louis et al.
2026-09-18 · DOI: 10.1111/ejh.70330Post‐Hoc Long‐Read Sequencing Links Leukemic Mutation Status to Single‐Cell Transcriptomes
Sofia Papavasileiou, Chenyan Wu, Daryl Boey, Lucille Margerie et al.
2026-09-17 · DOI: 10.1111/ejh.70322Impact of Vincristine Dose Reduction on Outcomes of Patients With Advanced‐Stage Diffuse Large B‐Cell Lymphoma Treated With R‐ CHOP
Jantina P. Kortleve, Sofie Engels, Berber A. Zweers, Yasmina Serroukh et al.
2026-09-16 · DOI: 10.1111/ejh.70321Toxicity‐Related Treatment Cessation in Newly Diagnosed Multiple Myeloma—Risk Factors and Survival: An Analysis From the APAC and ANZ Myeloma and Related Diseases Registry
Ji Hyun Lee, Sung‐Hyun Kim, Kihyun Kim, Elham Ashrafi et al.
2026-09-16 · DOI: 10.1111/ejh.70318From Prediction to Prevention: Validating the CLLAF Score Across Care Settings
Deen Dayal, Kundan Kumar Chaubey, Rajesh Prasad Jayaswal
2026-09-14 · DOI: 10.1111/ejh.70323Transplantation Strategies in Treatment of Primary Plasma Cell Leukemia in Germany—A Multi‐Center Analysis
Maria Dampmann, Sarah Flossdorf, Julius Keyl, Theo Leitner et al.
2026-09-11 · DOI: 10.1111/ejh.70319Serial VAF Kinetics Reveal Dynamic Clonal Evolution Associated With Progression in Clonal Cytopenia of Undetermined Significance
Zohre Sadeghian, Mark Jinan Chen, Kirill A. Lyapichev, Chieh‐Lin Fu et al.
2026-09-11 · DOI: 10.1111/ejh.70320Clinical Outcomes of Younger Adults With Philadelphia‐Negative Acute Lymphoblastic Leukemia, Treated With A Pediatric‐Like Regimen Based on the GIMEMA LAL1308 Protocol. A Campus ALL Study
Fabio Forghieri, Stefano Cordella, Davide Lazzarotto, Mario Annunziata et al.
2026-09-08 · DOI: 10.1111/ejh.70317Reviews
Community Reviews
Version History
October 4, 2026 at 8:59 pm
October 2, 2026